Zentalis Pharmaceuticals (ZNTL) Restructuring Costs (2025)
Zentalis Pharmaceuticals has reported Restructuring Costs over the past 1 years, most recently at $7.8 million for Q1 2025.
- For Q1 2025, Restructuring Costs changed N/A year-over-year to $7.8 million; the TTM value through Dec 2025 reached $7.8 million, changed N/A, while the annual FY2025 figure was $7.8 million, N/A changed from the prior year.
- Restructuring Costs for Q1 2025 was $7.8 million at Zentalis Pharmaceuticals.
- Over five years, Restructuring Costs peaked at $7.8 million in Q1 2025 and troughed at $7.8 million in Q1 2025.